Literature DB >> 3147111

Convulsion and coma after intranasal desmopressin in cystic fibrosis.

E J Simmonds1, M J Mahony, J M Little.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147111      PMCID: PMC1835280          DOI: 10.1136/bmj.297.6663.1614

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.

Authors:  S M Seif; T V Zenser; F F Ciarochi; B B Davis; A G Robinson
Journal:  J Clin Endocrinol Metab       Date:  1978-03       Impact factor: 5.958

2.  Pontine and extrapontine myelinolysis following rapid correction of hyponatraemia.

Authors:  R Laureno; B I Karp
Journal:  Lancet       Date:  1988-06-25       Impact factor: 79.321

3.  Desmopressin in nocturnal enuresis.

Authors:  M Aladjem; R Wohl; H Boichis; S Orda; D Lotan; S Freedman
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

4.  DDAVP and urine osmolality in refractory enuresis.

Authors:  S B Dimson
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

5.  Chloride impermeability in cystic fibrosis.

Authors:  P M Quinton
Journal:  Nature       Date:  1983-02-03       Impact factor: 49.962

  5 in total
  10 in total

Review 1.  Hyponatremia in patients with nocturnal enuresis treated with DDAVP.

Authors:  W L Robson; J P Nørgaard; A K Leung
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

2.  Dangers of intranasal desmopressin for nocturnal enuresis.

Authors:  M F Bamford; G Cruickshank
Journal:  J R Coll Gen Pract       Date:  1989-08

3.  Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis.

Authors:  D C Apakama; A Bleetman
Journal:  J Accid Emerg Med       Date:  1999-05

4.  Use caution in prescribing desmopressin for nocturnal enuresis.

Authors:  J Hourihane; A J Salisbury
Journal:  BMJ       Date:  1993-06-05

5.  Hyponatraemia following desmopressin.

Authors:  W L Robson; A K Leung
Journal:  BMJ       Date:  1993-07-03

6.  Hyponatraemia and cerebral convulsion due to short term DDAVP therapy for control of enuresis nocturna.

Authors:  M Schwab; D Wenzel; H Ruder
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

7.  Acute water intoxication after intranasal desmopressin in a patient with primary polydispsia.

Authors:  J Ferrer; I Halperin; J I Conget; J Cabrer; E Esmatjes; E Vilardell
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

Review 8.  Side effects and complications of treatment with desmopressin for enuresis.

Authors:  W L Robson; A K Leung
Journal:  J Natl Med Assoc       Date:  1994-10       Impact factor: 1.798

Review 9.  Drug therapy for nocturnal enuresis. Current treatment recommendations.

Authors:  K Miller; B Atkin; M L Moody
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 10.  Nocturnal enuresis.

Authors:  U S Alon
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.